Apcin
Cell permeable compound capable of slowing anaphase-promoting complex/cyclosome (APC/C)-dependent proteolysis. Inhibitor of the ubiquitin ligase activity of the APC/C by inhibiting substrate binding to Cdc20. Distinct mechanism of action than proTAME. Blocks mitotic exit only modestly when used alone in cultured cells. A strong synergistic effect is observed when Apcin and proTAME are used simultaneously, providing a more robust mitotic arrest. This may be very beneficial when treating cells that do not efficiently convert proTAME to its active parent compound (TAME) or if experiments demand strong APC/C inhibition.
Catalog Number | AG-CR1-3603-M005 |
Alternative Name(s) | Anaphase Promoting Complex Inhibitor |
Research Area | Biochemicals, Cancer, Cell Death |
Molecular Formula | C13H14Cl3N7O4 |
CAS# | 300815-04-7 |
Purity | >95% |
Inchi | InChI=1S/C13H14Cl3N7O4/c1-8-19-7-9(23(25)26)22(8)5-6-27-12(24)21-10(13(14,15)16)20-11-17-3-2-4-18-11/h2-4,7,10H,5-6H2,1H3,(H,21,24)(H,17,18,20) |
Inchi Key | ZEXHXVOGJFGTRX-UHFFFAOYSA-N |
SMILES | CC1=NC=C(N1CCOC(=O)NC(NC1=NC=CC=N1)C(Cl)(Cl)Cl)[N+]([O-])=O |
Size | 5 mg |
Supplier Page | http://www.adipogen.com/ag-cr1-3603/apcin.html |